Teichmann Sarah A. (CIK 2030916) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Sell TXG (5,278 shares), Sell TXG (2,273 shares), Buy TXG (8,829 shares), Sell TXG (7,579 shares), Buy TXG (15,357 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | 10x Genomics, Inc. (TXG) | Director | Sell | 5,278 | $302,377 |
| 2026-08-17 | 10x Genomics, Inc. (TXG) | Director | Sell | 2,273 | $129,902 |
| 2026-06-08 | 10x Genomics, Inc. (TXG) | Director | Buy | 8,829 | $0 |
| 2026-02-27 | 10x Genomics, Inc. (TXG) | Director | Sell | 7,579 | $147,108 |
| 2025-06-05 | 10x Genomics, Inc. (TXG) | Director | Buy | 15,357 | $0 |
Source: SEC Form 4 filings · as of 2026-08-17